# Berodual® Respimat® Solution for Inhalation in Patients With Chronic Obstructive Airways Disease

> **NCT02231372** · — · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 4602 (actual)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive

## Interventions

- **DRUG:** Berodual® Respimat® solution for inhalation

## Key facts

- **NCT ID:** NCT02231372
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2004-03
- **Primary completion:** 2004-12
- **Final completion:** —
- **Target enrollment:** 4602 (ACTUAL)
- **Last updated:** 2014-09-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02231372

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02231372, "Berodual® Respimat® Solution for Inhalation in Patients With Chronic Obstructive Airways Disease". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT02231372. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*